Corneal Toxicity Induced by ABT-414 Therapy for Glioblastoma Multiforme: A Case Report

Conclusions: The systemic use of EGFR inhibitor ABT-414 may be associated with corneal toxicity and the effects are reversible with treatment.Case Rep Ophthalmol 2018;9:479 –483
Source: Case Reports in Ophthalmology - Category: Opthalmology Source Type: research